Dağlı, P. A. Et Al. 2023. Tofacitinib experience in patients with enteropathic arthritis.. Immunotherapy , vol.15 , 619-626.

Dağlı, P. A., Erden, A., Güven, S. C., Armağan, B., Yürekli, Ö. T., Özin, Y. Ö., ... Omma, A.(2023). Tofacitinib experience in patients with enteropathic arthritis.. Immunotherapy , vol.15, 619-626.

Dağlı, Pınar Et Al. "Tofacitinib experience in patients with enteropathic arthritis.," Immunotherapy , vol.15, 619-626, 2023

Dağlı, Pınar A. Et Al. "Tofacitinib experience in patients with enteropathic arthritis.." Immunotherapy , vol.15, pp.619-626, 2023

Dağlı, P. A. Et Al. (2023) . "Tofacitinib experience in patients with enteropathic arthritis.." Immunotherapy , vol.15, pp.619-626.

@article{article, author={Pınar Akyüz Dağlı Et Al. }, title={Tofacitinib experience in patients with enteropathic arthritis.}, journal={Immunotherapy}, year=2023, pages={619-626} }